
Angiology, Год журнала: 2025, Номер unknown
Опубликована: Март 25, 2025
Язык: Английский
Angiology, Год журнала: 2025, Номер unknown
Опубликована: Март 25, 2025
Язык: Английский
Angiology, Год журнала: 2025, Номер unknown
Опубликована: Фев. 24, 2025
Язык: Английский
Процитировано
1Medicina, Год журнала: 2025, Номер 61(3), С. 487 - 487
Опубликована: Март 11, 2025
Background and Objectives: The prognostic value of Left Ventricular Global Function Index (LVGFI) in chronic cardiovascular diseases is well-documented; however, limited evidence exists for its utility non-ST elevation myocardial infarction (NSTEMI). This study aims to evaluate LVGFI as a predictor three-year mortality major adverse events (MACE) NSTEMI patients. Materials Methods: retrospective cohort included 432 patients divided into tertiles based on values: T1 (low), T2 (intermediate), T3 (high). values were derived from echocardiographic imaging. Kaplan–Meier survival analysis was used assess outcomes, the Cox proportional hazards models, adjusted demographics clinical covariates, determined association between outcomes. Results: average age sex distribution similar across with no significant differences risk factors or most laboratory parameters. However, noted body surface area (higher T3), platelet counts T1), triglyceride levels (lower T3). ROC identified an optimal cut-off 23.22 predicting mortality, sensitivity 72% specificity 75% (AUC: 0.81; 95% CI: 0.74–0.87, p < 0.001). Patients exhibited rate 25%, compared 2.1% T3. After adjustment, hazard ratio (HR) significantly higher (HR 11.86; 3.60–39.10) Similarly, MACE rates highest (27.1%) lowest (7.6%). Conclusions: independent
Язык: Английский
Процитировано
0Angiology, Год журнала: 2025, Номер unknown
Опубликована: Март 25, 2025
Язык: Английский
Процитировано
0